Growth hormone receptor expression in brain tumors

Area of Science:

• Neuro-oncology
• Endocrinology
• Molecular Biology

Background:

• Growth hormone (GH) is crucial for life quality but may promote neoplasm growth.
• The specific role of GH in brain tumors remains unclear.
• Understanding GH receptor (GHR) expression is key to clarifying GH's role in brain tumors.

Purpose of the Study:

• To investigate GH receptor (GHR) expression in various human brain tumors.
• To correlate GHR expression with clinical features of brain tumors.

Main Methods:

• Immunohistochemistry was used to examine GHR expression in surgical specimens from 106 pituitary adenomas, 12 craniopharyngiomas, 13 germ cell tumors, 6 medulloblastomas, and 12 malignant gliomas.
• GHR expression levels were analyzed and compared between different tumor types and with clinical data.

Main Results:

• GHR positive rates were lower in malignant tumors (0% in medulloblastomas and gliomas) compared to benign tumors (59% in pituitary adenomas, 73% in craniopharyngiomas).
• GHR staining was weaker in pituitary adenomas than in normal pituitary glands.
• In non-GH-producing pituitary adenomas, GHR-positive tumors were significantly smaller than GHR-negative tumors.

Conclusions:

• Immunohistochemical GHR expression may partially inhibit brain tumor growth potential.
• GHR expression levels differ significantly between benign and malignant brain tumors.
• GHR may play a role in regulating the growth of specific brain tumor types, particularly pituitary adenomas.